The Octagon at the Assembly Rooms
Octagon Room, Assembly Rooms, Bath
Royal Pump Room, Harrogate
The Royal Pump Room, Harrogate
Royal Pump Room, Harrogate
The Roman Baths Entrance

Confirmed Speaker Faculty
14th – 15th July 2008 Bath
Postponed until Autumn

Derek Butler MRSA Action Group
Paul Cryer Programme Manager, NHS Purchasing and Supply Agency
Richard Cunningham Consultant Microbiologist, Plymouth Hospitals NHS Trust
Brian Duerden Inspector of Microbiology and Infection Control at the Department of Health, London
Vanja Gant Clinical Director of Pathology, University College Hospitals NHS Foundation Trust
Annette Jeanes Consultant Nurse Infection Control, Director of Infection Prevention & Control University College Hospitals NHS Foundation Trust
Peter Jenks Director of Infection Control and Prevention, Plymouth Hospitals NHS Trust
Simon Lindsay Bevan Brittan Solicitors, Bristol
Ruth McCathy Associate Director Clinical Governance/DIPC, Swindon & Marlborough NHS Trust
Colin Ovington Director for Infection Control, NHS London
Michael Millar Consultant Microbiologist/Honorary Senior Lecturer Department of Medical Microbiology, St Barts and The London Hospitals
   
Kathy L. Warye
Overseas Speaker		 Kathy WaryeChief Executive Officer of the Association for Professionals in Infection Control and Epidemiology, Washington, D.C., U.S.A.

Provisional Programme Topics - Bath

14th July Plenary Sessions

  • 12:00 Registration and Networking Lunch
  • Driving down HCAI in the NHS - the next phase
  • The Legal Cost of Getting Infection Control Wrong
  • Best Practice Considerations: Health Commission Discoveries
  • Integrating IP & C within the Organisational Quality and Risk Management Framework
  • Cost Benefit Analysis: the advantages of prevention and control
  • Status of MRSA in US, APIC Guide to MRSA and C.diff Guide to Elimination
  • Networking Dinner

15th July Plenary Sessions & Seminars

  • 08:00 Breakfast Networking
  • Risk Assessment and Screening: from C.diff to ESBLs
  • Environmental Issues
  • Patient Partnerships
  • Reducing Antimicrobial Prescribing for MRSA/C.diff
  • Saving Lives: High Impact Interventions
  • Implementation of National Guidance on MRSA Screening
  • Using Surgical Site Surveillance and MRSA screening to drive down infection rates
  • Proton Pump Inhibitors As a Risk Factor for C.diff
  • Case for Improved Environment
  • Promoting and Infection Control Culture: Change Management
  • 15:30 Close